Up a level |
Lourenco, J, Obolski, U, Swarthout, TD, Gori, A, Bar-Zeev, N, Everett, D, Kamng'ona, AW ORCID: 0000-0002-0841-7586, Mwalukomo, TS, Mataya, AA, Mwansambo, C et al (show 4 more authors)
(2019)
Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study.
BMC MEDICINE, 17 (1).
219-.
Bennett, A ORCID: 0000-0003-4240-1972, Pollock, L ORCID: 0000-0002-4240-325X, Jere, KC ORCID: 0000-0003-3376-8529, Pitzer, VE, Parashar, U, Tate, JE, Heyderman, RS ORCID: 0000-0003-4573-449X, Mwansambo, C, French, N ORCID: 0000-0003-4814-8293, Nakagomi, O et al (show 5 more authors)
(2018)
Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
Vaccine, 36 (47).
pp. 7142-7148.
Bar-Zeev, N, Swarthout, TD and Everett, DB
(2021)
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies (vol 9, pg e989, 2021).
LANCET GLOBAL HEALTH, 9 (12).
E1657-E1657.
Bar-Zeev, N ORCID: 0000-0003-0570-4624, Jere, KC ORCID: 0000-0003-3376-8529, Bennett, A, Pollock, L, Tate, JE, Nakagomi, O, Iturriza-Gomara, M ORCID: 0000-0001-5816-6423, Costello, A, Mwansambo, C, Parashar, UD et al (show 3 more authors)
(2016)
Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.
Clinical Infectious Diseases, 62 (Supple).
S213-S219.
Luthra, K, Watts, E, Debellut, F, Pecenka, C, Bar-Zeev, N ORCID: 0000-0003-0570-4624 and Constenla, D
(2019)
A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.
CLINICAL INFECTIOUS DISEASES, 68 (Suppl ).
S83-S95.
Alam, T, Ahmed, D, Ahmed, T, Chisti, MJ, Rahman, MW, Asthana, AK, Bansal, PK, Chouhan, A, Deb, S, Dhingra, P et al (show 47 more authors)
(2020)
A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol.
TRIALS, 21 (1).
71-.